Skip to main content
Caplight Logo









Emblok

Emblok

Private
Grand Rapids, MichiganHealthcare & Life Scienceshttps://emblok.com

Last Round

Seed Round

May 21, 2026

Total Funding Raised

$18M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Emblok operates in Healthcare & Life Sciences and is based in Grand Rapids, Michigan. Its latest recorded funding round was a Series C round in December 2018.

Emblok is a surgical devices company that has developed a whole-body embolic protection system designed to offer protection from material released during left-sided cardiovascular procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Emblok Comparables

Compare Emblok with similar companies based on industry and business-model similarity.

Emblok comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Emboline
94%
EmStop, Inc.
92%
Filterlex Medical
92%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Emblok Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundMay 21, 2026
Series CDec 18, 2018
Series BJul 11, 2017
Series ANov 27, 2014
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Bradley Brown

President and CEO

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 21, 2026

    Raised $6M in seed funding.

  • Apr 18, 2026

    Monthly visitors grew 81% MoM, reaching 288.

Book a demo to see all signals

For institutional investors. Book with your work email.

Emblok Filings

Explore SEC and related filing metadata, where available.

Emblok filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Emblok's valuation, stock price, and market status.

Is Emblok a public or private company?

Emblok is a private company.

What is the current stock price of Emblok?

Emblok is a private company, so its shares have no public market price. Caplight tracks Emblok's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Emblok worth (valuation)?

Valuation information for Emblok is not publicly available.

Can I buy Emblok stock?

Emblok shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Emblok's last funding round?

Emblok's most recent funding round was Seed Round on May 21, 2026.

Who are the main investors in Emblok?

Investor information for Emblok is not publicly disclosed.

Will Emblok IPO soon?

No public IPO plans have been announced for Emblok.

How can I track Emblok secondary market activity?

Caplight tracks bids, offers, and trades in Emblok's shares on secondary markets.

Firmographic Details

HeadquartersGrand Rapids, Michigan
Employee Range8
Year Founded2012
Last FundingMay 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?